{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:27:45Z","timestamp":1786991265141,"version":"build-2736575974"},"reference-count":75,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,3]],"date-time":"2022-09-03T00:00:00Z","timestamp":1662163200000},"content-version":"am","delay-in-days":367,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.jaci.2021.03.026","type":"journal-article","created":{"date-parts":[[2021,4,2]],"date-time":"2021-04-02T11:25:02Z","timestamp":1617362702000},"page":"822-834","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Efficacy of medical treatments for vernal keratoconjunctivitis: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"148","author":[{"given":"In\u00e8s","family":"Roumeau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrien","family":"Coutu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6317-345X","authenticated-orcid":false,"given":"Valentin","family":"Navel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien S.","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Chiambaretta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Bremond-Gignac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Dutheil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2021.03.026_bib1","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s40123-013-0019-y","article-title":"Management of vernal keratoconjunctivitis","volume":"2","author":"Leonardi","year":"2013","journal-title":"Ophthalmol Ther"},{"key":"10.1016\/j.jaci.2021.03.026_bib2","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1136\/bjo.2007.117812","article-title":"Prevalence of vernal keratoconjunctivitis: a rare disease?","volume":"92","author":"Bremond-Gignac","year":"2008","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jaci.2021.03.026_bib3","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1016\/j.ophtha.2012.03.041","article-title":"Vernal keratoconjunctivitis in school children in Rwanda: clinical presentation, impact on school attendance, and access to medical care","volume":"119","author":"De Smedt","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jaci.2021.03.026_bib4","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s40272-016-0185-1","article-title":"An update on the therapeutic approach to vernal keratoconjunctivitis","volume":"18","author":"Esposito","year":"2016","journal-title":"Paediatr Drugs"},{"key":"10.1016\/j.jaci.2021.03.026_bib5","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.jtos.2020.10.005","article-title":"Management of corneal complications in vernal keratoconjunctivitis: a review","volume":"19","author":"Feizi","year":"2021","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jaci.2021.03.026_bib6","doi-asserted-by":"crossref","first-page":"145","DOI":"10.4103\/0301-4738.179727","article-title":"Systematic approach to managing vernal keratoconjunctivitis in clinical practice: severity grading system and a treatment algorithm","volume":"64","author":"Gokhale","year":"2016","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.jaci.2021.03.026_bib7","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.2165\/00003495-200262110-00004","article-title":"Ocular allergy guidelines: a practical treatment algorithm","volume":"62","author":"Bielory","year":"2002","journal-title":"Drugs"},{"key":"10.1016\/j.jaci.2021.03.026_bib8","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1755-3768.2008.01347.x","article-title":"Vernal keratoconjunctivitis: a major review","volume":"87","author":"Kumar","year":"2009","journal-title":"Acta Ophthalmol (Copenh)"},{"key":"10.1016\/j.jaci.2021.03.026_bib9","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s13052-019-0656-4","article-title":"Vernal keratoconjunctivitis: an update focused on clinical grading system","volume":"45","author":"Zicari","year":"2019","journal-title":"Ital J Pediatr"},{"key":"10.1016\/j.jaci.2021.03.026_bib10","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1136\/bmj.323.7308.334","article-title":"A new system for grading recommendations in evidence based guidelines","volume":"323","author":"Harbour","year":"2001","journal-title":"BMJ"},{"key":"10.1016\/j.jaci.2021.03.026_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0195166","article-title":"Heart rate variability in type 2 diabetes mellitus: a systematic review and meta-analysis","volume":"13","author":"Benichou","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.jaci.2021.03.026_bib12","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1167\/tvst.8.3.38","article-title":"Efficacy of different procedures of intra-corneal ring segment implantation in keratoconus: a systematic review and meta-analysis","volume":"8","author":"Benoist d\u2019Azy","year":"2019","journal-title":"Transl Vis Sci Technol"},{"key":"10.1016\/j.jaci.2021.03.026_bib13","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.jtos.2019.06.004","article-title":"Efficacy of treatments for Demodex blepharitis: a systematic review and meta-analysis","volume":"17","author":"Navel","year":"2019","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jaci.2021.03.026_bib14","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/ijcp.12435","article-title":"Paging Dr Cohen, Paging Dr Cohen . . . an effect size interpretation is required STAT!: visualising effect size and an interview with Kristoffer Magnusson","volume":"68","author":"Citrome","year":"2014","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.jaci.2021.03.026_bib15","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0161-6420(99)00096-2","article-title":"A randomized trial of low-dose, topical mitomycin-C in the treatment of severe vernal keratoconjunctivitis","volume":"107","author":"Akpek","year":"2000","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jaci.2021.03.026_bib16","doi-asserted-by":"crossref","first-page":"135","DOI":"10.4103\/0974-9233.164616","article-title":"tacrolimus ointment for treatment of vernal keratoconjunctivitis","volume":"23","author":"Al-Amri","year":"2016","journal-title":"Middle East Afr J Ophthalmol"},{"key":"10.1016\/j.jaci.2021.03.026_bib17","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/S0161-6420(00)00089-0","article-title":"Mechanisms and comparison of anti-allergic efficacy of topical lodoxamide and cromolyn sodium treatment in vernal keratoconjunctivitis","volume":"107","author":"Avunduk","year":"2000","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jaci.2021.03.026_bib18","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1159\/000050876","article-title":"Cyclosporine effects on clinical findings and impression cytology specimens in severe vernal keratoconjunctivitis","volume":"215","author":"Avunduk","year":"2001","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.jaci.2021.03.026_bib19","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1016\/S0161-6420(91)32069-4","article-title":"Topical cyclosporine in vernal keratoconjunctivitis","volume":"98","author":"Bleik","year":"1991","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jaci.2021.03.026_bib20","first-page":"422","article-title":"Efficacy of mipragoside ophthalmic gel in vernal keratoconjunctivitis","volume":"10","author":"Centofanti","year":"1996","journal-title":"Eye Lond Engl"},{"key":"10.1016\/j.jaci.2021.03.026_bib21","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1089\/jop.2005.21.400","article-title":"Efficiency of olopatadine hydrochloride 0.1% in the treatment of vernal keratoconjunctivitis and goblet cell density","volume":"21","author":"Corum","year":"2005","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.jaci.2021.03.026_bib22","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/s00417-002-0612-6","article-title":"Preservative-free diclofenac sodium 0.1% for vernal keratoconjunctivitis","volume":"241","author":"D\u2019Angelo","year":"2003","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.jaci.2021.03.026_bib23","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0181-5512(07)91357-1","article-title":"Efficacit\u00e9 de la ciclosporine A\u00a0en collyre \u00e0 2 % en tant qu\u2019\u00e9pargneur de cortico\u00efdes dans le traitement de la k\u00e9ratoconjonctivite vernale corticod\u00e9pendante","volume":"30","author":"Doan","year":"2007","journal-title":"J Fr Ophtalmol"},{"key":"10.1016\/j.jaci.2021.03.026_bib24","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1365-2222.1972.tb01274.x","article-title":"Clinical trial of topical disodium cromoglycate in vernal kerato-conjunctivitis","volume":"2","author":"Easty","year":"1972","journal-title":"Clin Allergy"},{"key":"10.1016\/j.jaci.2021.03.026_bib25","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1136\/bjo.78.5.365","article-title":"A double blind placebo controlled group comparative study of ophthalmic sodium cromoglycate and nedocromil sodium in the treatment of vernal keratoconjunctivitis","volume":"78","author":"el Hennawi","year":"1994","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jaci.2021.03.026_bib26","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0002-9394(14)74850-0","article-title":"Randomized clinical trial of topically administered cromolyn sodium for vernal keratoconjunctivitis","volume":"90","author":"Foster","year":"1980","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jaci.2021.03.026_bib27","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0161-6420(88)33201-X","article-title":"Evaluation of topical cromolyn sodium in the treatment of vernal keratoconjunctivitis","volume":"95","author":"Foster","year":"1988","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jaci.2021.03.026_bib28","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1159\/000267878","article-title":"Efficacy of lodoxamide 0.1% versus N-acetyl aspartyl glutamic acid 6% ophthalmic solutions in patients with vernal keratoconjunctivitis","volume":"28","author":"G\u00fcnd\u00fcz","year":"1996","journal-title":"Ophthalmic Res"},{"key":"10.1016\/j.jaci.2021.03.026_bib29","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1590\/S0004-27492006000600013","article-title":"[Comparative study between 0.025% ketotifen fumarate and 0.1% olopatadine hydrochloride in the treatment of vernal keratoconjunctivitis]","volume":"69","author":"Hida","year":"2006","journal-title":"Arq Bras Oftalmol"},{"key":"10.1016\/j.jaci.2021.03.026_bib30","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s00417-007-0682-6","article-title":"Preliminary evidence of the efficacy of probiotic eye-drop treatment in patients with vernal keratoconjunctivitis","volume":"246","author":"Iovieno","year":"2008","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.jaci.2021.03.026_bib31","doi-asserted-by":"crossref","first-page":"111","DOI":"10.4103\/0301-4738.25832","article-title":"Low dose mitomycin-C in severe vernal keratoconjunctivitis: a randomized prospective double blind study","volume":"54","author":"Jain","year":"2006","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.jaci.2021.03.026_bib32","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s10384-008-0577-z","article-title":"Efficacy of topical cyclosporin A\u00a00.05% in conjunctival impression cytology specimens and clinical findings of severe vernal keratoconjunctivitis in children","volume":"52","author":"Keklikci","year":"2008","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/j.jaci.2021.03.026_bib33","doi-asserted-by":"crossref","first-page":"455","DOI":"10.17219\/acem\/37145","article-title":"Topical cyclosporine a 0.05% eyedrops in the treatment of vernal keratoconjunctivitis: randomized placebo-controlled trial","volume":"23","author":"Keklikci","year":"2014","journal-title":"Adv Clin Exp Med"},{"key":"10.1016\/j.jaci.2021.03.026_bib34","first-page":"872","article-title":"Topical 0.005% tacrolimus eye drop for refractory vernal keratoconjunctivitis","volume":"25","author":"Kheirkhah","year":"2011","journal-title":"Eye Lond Engl"},{"key":"10.1016\/j.jaci.2021.03.026_bib35","doi-asserted-by":"crossref","first-page":"693","DOI":"10.3129\/i06-061","article-title":"Topical 2% cyclosporine A\u00a0in preservative-free artificial tears for the treatment of vernal keratoconjunctivitis","volume":"41","author":"Kili\u00e7","year":"2006","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.jaci.2021.03.026_bib36","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3126\/nepjoph.v9i2.19257","article-title":"Tacrolimus versus cyclosporine- comparative evaluation as first line drug in vernal keratoconjuctivitis","volume":"9","author":"Kumari","year":"2017","journal-title":"Nepal J Ophthalmol"},{"key":"10.1016\/j.jaci.2021.03.026_bib37","first-page":"177","article-title":"A double-masked comparison of 0.1% tacrolimus ointment and 2% cyclosporine eye drops in the treatment of vernal keratoconjunctivitis in children","volume":"30","author":"Labcharoenwongs","year":"2012","journal-title":"Asian Pac J Allergy Immunol"},{"key":"10.1016\/j.jaci.2021.03.026_bib38","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1001\/archopht.121.5.615","article-title":"Montelukast, a leukotriene receptor antagonist, in vernal keratoconjunctivitis associated with asthma","volume":"121","author":"Lambiase","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jaci.2021.03.026_bib39","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1136\/bjo.81.1.23","article-title":"Effect of lodoxamide and disodium cromoglycate on tear eosinophil cationic protein in vernal keratoconjunctivitis","volume":"81","author":"Leonardi","year":"1997","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jaci.2021.03.026_bib40","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1136\/bjo.2007.117515","article-title":"Clinical and biological efficacy of preservative-free NAAGA eye-drops versus levocabastine eye-drops in vernal keratoconjunctivitis patients","volume":"91","author":"Leonardi","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jaci.2021.03.026_bib41","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.ophtha.2018.12.027","article-title":"A randomized, controlled trial of cyclosporine A\u00a0cationic emulsion in pediatric vernal keratoconjunctivitis: the VEKTIS study","volume":"126","author":"Leonardi","year":"2019","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jaci.2021.03.026_bib42","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1136\/bjo.71.7.497","article-title":"Efficacy of antiprostaglandin therapy in vernal conjunctivitis","volume":"71","author":"Meyer","year":"1987","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jaci.2021.03.026_bib43","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/ICL.0000000000000001","article-title":"Topical tacrolimus 0.03% as sole therapy in vernal keratoconjunctivitis: a randomized double-masked study","volume":"40","author":"M\u00fcller","year":"2014","journal-title":"Eye Contact Lens"},{"key":"10.1016\/j.jaci.2021.03.026_bib44","doi-asserted-by":"crossref","first-page":"154","DOI":"10.5935\/0004-2749.20170038","article-title":"Tacrolimus eye drops as monotherapy for vernal keratoconjunctivitis: a randomized controlled trial","volume":"80","author":"M\u00fcller","year":"2017","journal-title":"Arq Bras Oftalmol"},{"key":"10.1016\/j.jaci.2021.03.026_bib45","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/1061276","article-title":"Tear ferning test and pathological effects on ocular surface before and after topical cyclosporine in vernal keratoconjunctivitis patients","volume":"2018","author":"Nebbioso","year":"2018","journal-title":"J Ophthalmol"},{"key":"10.1016\/j.jaci.2021.03.026_bib46","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1007\/s10384-012-0152-5","article-title":"Topical loteprednol etabonate 0.5 % for treatment of vernal keratoconjunctivitis: efficacy and safety","volume":"56","author":"Oner","year":"2012","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/j.jaci.2021.03.026_bib47","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1097\/ICO.0b013e31828ffdf8","article-title":"Tear cytokine levels in vernal keratoconjunctivitis: the effect of topical 0.05% cyclosporine a therapy","volume":"32","author":"Oray","year":"2013","journal-title":"Cornea"},{"key":"10.1016\/j.jaci.2021.03.026_bib48","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S1081-1206(10)61958-8","article-title":"Efficacy and safety of cyclosporine eyedrops in vernal keratoconjunctivitis","volume":"89","author":"Pucci","year":"2002","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2021.03.026_bib49","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/pai.12360","article-title":"Tacrolimus vs. cyclosporine eyedrops in severe cyclosporine-resistant vernal keratoconjunctivitis: a randomized, comparative, double-blind, crossover study","volume":"26","author":"Pucci","year":"2015","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.jaci.2021.03.026_bib50","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0002-9394(14)77061-8","article-title":"Topical use of cyclosporine in the treatment of vernal keratoconjunctivitis","volume":"110","author":"Secchi","year":"1990","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jaci.2021.03.026_bib51","first-page":"177","article-title":"Topical ketorolac 0.5% solution for the treatment of vernal keratoconjunctivitis","volume":"45","author":"Sharma","year":"1997","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.jaci.2021.03.026_bib52","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1399-3038.2006.00427.x","article-title":"Efficacy of 1.25% and 1% topical cyclosporine in the treatment of severe vernal keratoconjunctivitis in childhood","volume":"17","author":"Spadavecchia","year":"2006","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.jaci.2021.03.026_bib53","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/j.1399-3038.2009.00948.x","article-title":"Treatment of severe vernal keratoconjunctivitis with 1% topical cyclosporine in an Italian cohort of 197 children","volume":"21","author":"Tesse","year":"2010","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.jaci.2021.03.026_bib54","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3109\/09273948.2012.656877","article-title":"The efficacy of topical interferon alpha 2b treatment in refractory vernal keratoconjunctivitis","volume":"20","author":"Turan-Vural","year":"2012","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.jaci.2021.03.026_bib55","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1046\/j.1365-2222.1999.00501.x","article-title":"Nedocromil sodium eye drops are more effective than sodium cromoglycate eye drops for the long-term management of vernal keratoconjunctivitis","volume":"29","author":"Verin","year":"1999","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2021.03.026_bib56","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1177\/112067210101100203","article-title":"Comparison of lodoxamide 0.1% ophthalmic solution and levocabastine 0.05% ophthalmic suspension in vernal keratoconjunctivitis","volume":"11","author":"Verin","year":"2001","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.jaci.2021.03.026_bib57","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.jaci.2003.10.065","article-title":"Vernal keratoconjunctivitis: result of a novel therapy with 0.1% topical ophthalmic FK-506 ointment","volume":"113","author":"Vichyanond","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.03.026_bib58","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1159\/000478704","article-title":"Therapeutic effect of 0.1% tacrolimus eye drops in the tarsal form of vernal keratoconjunctivitis","volume":"59","author":"Wan","year":"2018","journal-title":"Ophthalmic Res"},{"key":"10.1016\/j.jaci.2021.03.026_bib59","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1097\/ICO.0000000000001200","article-title":"Comparative evaluation of tacrolimus versus interferon alpha-2b eye drops in the treatment of vernal keratoconjunctivitis: a randomized, double-masked study","volume":"36","author":"Zanjani","year":"2017","journal-title":"Cornea"},{"key":"10.1016\/j.jaci.2021.03.026_bib60","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/ACI.0000000000000473","article-title":"Topical antihistamines, mast cell stabilizers, and dual-action agents in ocular allergy: current trends","volume":"18","author":"Ben-Eli","year":"2018","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.03.026_bib61","doi-asserted-by":"crossref","first-page":"119","DOI":"10.2147\/OPTH.S129552","article-title":"Vernal keratoconjunctivitis","volume":"12","author":"Addis","year":"2018","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.jaci.2021.03.026_bib62","doi-asserted-by":"crossref","first-page":"398","DOI":"10.18502\/jovr.v14i4.5435","article-title":"Topical calcineurin inhibitors: expanding indications for corneal and ocular surface inflammation","volume":"14","author":"Ghasemi","year":"2019","journal-title":"J Ophthalmic Vis Res"},{"key":"10.1016\/j.jaci.2021.03.026_bib63","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ejpb.2017.03.006","article-title":"Cyclosporine A\u00a0delivery to the eye: a comprehensive review of academic and industrial efforts","volume":"117","author":"Lallemand","year":"2017","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.jaci.2021.03.026_bib64","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.2147\/OPTH.S181811","article-title":"Eye drop emulsion containing 0.1% cyclosporin (1 mg\/mL) for the treatment of severe vernal keratoconjunctivitis: an evidence-based review and place in therapy","volume":"13","author":"Nebbioso","year":"2019","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.jaci.2021.03.026_bib65","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/S0161-6420(00)00092-0","article-title":"Vernal keratoconjunctivitis revisited: a case series of 195 patients with long-term followup","volume":"107","author":"Bonini","year":"2000","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jaci.2021.03.026_bib66","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1080\/09286580802573177","article-title":"Prospective, multicenter demographic and epidemiological study on vernal keratoconjunctivitis: a glimpse of ocular surface in Italian population","volume":"16","author":"Lambiase","year":"2009","journal-title":"Ophthalmic Epidemiol"},{"key":"10.1016\/j.jaci.2021.03.026_bib67","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/pai.12737","article-title":"Vernal keratoconjunctivitis treated with omalizumab: a case series","volume":"28","author":"Occasi","year":"2017","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.jaci.2021.03.026_bib68","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s40123-016-0074-2","article-title":"Omalizumab in severe refractory vernal keratoconjunctivitis in children: case series and review of the literature","volume":"6","author":"Doan","year":"2017","journal-title":"Ophthalmol Ther"},{"key":"10.1016\/j.jaci.2021.03.026_bib69","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1001\/jamaophthalmol.2015.5679","article-title":"Omalizumab treatment of vernal keratoconjunctivitis","volume":"134","author":"Heffler","year":"2016","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.jaci.2021.03.026_bib70","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1007\/s00417-019-04389-w","article-title":"One-year evaluation of clinical and immunological efficacy and safety of sublingual versus subcutaneous allergen immunotherapy in allergic conjunctivitis","volume":"257","author":"Sayed","year":"2019","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.jaci.2021.03.026_bib71","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1097\/ACI.0000000000000692","article-title":"Use of allergen immunotherapy for treatment\u00a0of allergic conjunctivitis","volume":"20","author":"Norris","year":"2020","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.03.026_bib72","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/ICO.0b013e3181eae270","article-title":"Subcutaneous allergen-specific immunotherapy versus topical treatment in vernal keratoconjunctivitis","volume":"31","author":"Mahdy","year":"2012","journal-title":"Cornea"},{"key":"10.1016\/j.jaci.2021.03.026_bib73","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1136\/bjo.2007.122044","article-title":"Systematic review and meta-analysis of randomised clinical trials on topical treatments for vernal keratoconjunctivitis","volume":"91","author":"Mantelli","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jaci.2021.03.026_bib74","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.ajo.2012.11.018","article-title":"Vernal keratoconjunctivitis-like disease in adults","volume":"155","author":"Leonardi","year":"2013","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jaci.2021.03.026_bib75","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.ophtha.2015.07.012","article-title":"Atopic keratoconjunctivitis in children: clinical features and diagnosis","volume":"123","author":"Br\u00e9mond-Gignac","year":"2016","journal-title":"Ophthalmology"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674921005480?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674921005480?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T09:32:47Z","timestamp":1758792767000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674921005480"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":75,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S0091674921005480"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2021.03.026","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of medical treatments for vernal keratoconjunctivitis: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2021.03.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}